Avid Bioservices Inc (CDMO)

[hutschi]

BUZZ-Peregrine Pharmaceuticals Inc: Cancer drug shows promise in animal study

09-Feb-2015 14:35

** Cancer drug developer's shares PPHM.O up 6.56 pct at
$1.30
** Company says combination of its cancer rug, bavituximab, with anti-PD-1 antibody was better at fighting cancer in pre-clinical trials than a anti-PD-1 antibody alone (nMKWlJlv1a)
** Bavituximab, a PS-targeting antibody, blocks cells that suppress the body's immunity to cancer cells, while an anti-PD-1 antibody activates the body's defenses against tumor cells
** Company says data showed the combination treatment reduced by more than 40 pct the number of cells that suppress the immune system from recognizing tumors
** Up to Friday's close, the stock had fallen 12 pct so far this year